Logo image of GH

GUARDANT HEALTH INC (GH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GH - US40131M1099 - Common Stock

101.74 USD
-0.4 (-0.39%)
Last: 1/2/2026, 8:00:01 PM
101.74 USD
0 (0%)
After Hours: 1/2/2026, 8:00:01 PM
Fundamental Rating

3

GH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. GH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GH had negative earnings in the past year.
In the past year GH has reported a negative cash flow from operations.
GH had negative earnings in each of the past 5 years.
GH had a negative operating cash flow in each of the past 5 years.
GH Yearly Net Income VS EBIT VS OCF VS FCFGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

GH has a worse Return On Assets (-31.23%) than 83.17% of its industry peers.
Industry RankSector Rank
ROA -31.23%
ROE N/A
ROIC N/A
ROA(3y)-32.29%
ROA(5y)-25.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GH Yearly ROA, ROE, ROICGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

GH has a better Gross Margin (63.76%) than 84.16% of its industry peers.
In the last couple of years the Gross Margin of GH has declined.
GH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5Y-1.93%
GH Yearly Profit, Operating, Gross MarginsGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GH has been increased compared to 1 year ago.
The number of shares outstanding for GH has been increased compared to 5 years ago.
GH has a worse debt/assets ratio than last year.
GH Yearly Shares OutstandingGH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GH Yearly Total Debt VS Total AssetsGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

GH has an Altman-Z score of 1.82. This is not the best score and indicates that GH is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of GH (1.82) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.82
ROIC/WACCN/A
WACC8.97%
GH Yearly LT Debt VS Equity VS FCFGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.50 indicates that GH has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.50, GH belongs to the best of the industry, outperforming 87.13% of the companies in the same industry.
GH has a Quick Ratio of 3.12. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.12, GH belongs to the best of the industry, outperforming 85.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 3.12
GH Yearly Current Assets VS Current LiabilitesGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

GH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.21%.
The Revenue has grown by 30.38% in the past year. This is a very strong growth!
Measured over the past years, GH shows a very strong growth in Revenue. The Revenue has been growing by 28.08% on average per year.
EPS 1Y (TTM)1.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.91%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y25.52%
Revenue growth 5Y28.08%
Sales Q2Q%38.5%

3.2 Future

The Earnings Per Share is expected to grow by 18.49% on average over the next years. This is quite good.
Based on estimates for the next years, GH will show a very strong growth in Revenue. The Revenue will grow by 27.73% on average per year.
EPS Next Y33.8%
EPS Next 2Y15.27%
EPS Next 3Y16.41%
EPS Next 5Y18.49%
Revenue Next Year32.84%
Revenue Next 2Y29.78%
Revenue Next 3Y29.13%
Revenue Next 5Y27.73%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GH Yearly Revenue VS EstimatesGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
GH Yearly EPS VS EstimatesGH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4 6 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GH. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GH Price Earnings VS Forward Price EarningsGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GH Per share dataGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as GH's earnings are expected to grow with 16.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.27%
EPS Next 3Y16.41%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

GUARDANT HEALTH INC

NASDAQ:GH (1/2/2026, 8:00:01 PM)

After market: 101.74 0 (0%)

101.74

-0.4 (-0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-18 2026-02-18/amc
Inst Owners97.26%
Inst Owner Change-1.25%
Ins Owners4.04%
Ins Owner Change-2.51%
Market Cap13.11B
Revenue(TTM)902.57M
Net Income(TTM)-398.79M
Analysts86.06
Price Target109.15 (7.28%)
Short Float %7.98%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.57%
Min EPS beat(2)-2.26%
Max EPS beat(2)-0.89%
EPS beat(4)0
Avg EPS beat(4)-5.38%
Min EPS beat(4)-18.05%
Max EPS beat(4)-0.34%
EPS beat(8)1
Avg EPS beat(8)-3.14%
EPS beat(12)5
Avg EPS beat(12)4.15%
EPS beat(16)7
Avg EPS beat(16)3.82%
Revenue beat(2)2
Avg Revenue beat(2)7.96%
Min Revenue beat(2)6.68%
Max Revenue beat(2)9.24%
Revenue beat(4)4
Avg Revenue beat(4)5.45%
Min Revenue beat(4)1.97%
Max Revenue beat(4)9.24%
Revenue beat(8)8
Avg Revenue beat(8)5.72%
Revenue beat(12)11
Avg Revenue beat(12)4.58%
Revenue beat(16)13
Avg Revenue beat(16)3.54%
PT rev (1m)9.57%
PT rev (3m)78.14%
EPS NQ rev (1m)15.23%
EPS NQ rev (3m)10.21%
EPS NY rev (1m)26.22%
EPS NY rev (3m)25.7%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)6.94%
Revenue NY rev (1m)0.78%
Revenue NY rev (3m)5.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.26
EYN/A
EPS(NY)-2.39
Fwd EYN/A
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS7.01
BVpS-2.75
TBVpS-2.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.76%
FCFM N/A
ROA(3y)-32.29%
ROA(5y)-25.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5Y-1.93%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.99%
Cap/Sales 4.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.5
Quick Ratio 3.12
Altman-Z 1.82
F-Score5
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)115.32%
Cap/Depr(5y)203.86%
Cap/Sales(3y)8.54%
Cap/Sales(5y)12.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.91%
EPS Next Y33.8%
EPS Next 2Y15.27%
EPS Next 3Y16.41%
EPS Next 5Y18.49%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y25.52%
Revenue growth 5Y28.08%
Sales Q2Q%38.5%
Revenue Next Year32.84%
Revenue Next 2Y29.78%
Revenue Next 3Y29.13%
Revenue Next 5Y27.73%
EBIT growth 1Y14.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.11%
EBIT Next 3Y25.17%
EBIT Next 5Y21.53%
FCF growth 1Y27.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.86%
OCF growth 3YN/A
OCF growth 5YN/A

GUARDANT HEALTH INC / GH FAQ

What is the ChartMill fundamental rating of GUARDANT HEALTH INC (GH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GH.


What is the valuation status for GH stock?

ChartMill assigns a valuation rating of 0 / 10 to GUARDANT HEALTH INC (GH). This can be considered as Overvalued.


What is the profitability of GH stock?

GUARDANT HEALTH INC (GH) has a profitability rating of 1 / 10.


Can you provide the financial health for GH stock?

The financial health rating of GUARDANT HEALTH INC (GH) is 4 / 10.